Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR‐138‐5p and activation of AKT/mTOR signaling pathway

Published:2021-02 Issue:1 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol. Res. Perspect.

Author:

Huang Guolin¹,Li Li¹,Liang Chaoyong²,Yu Fei¹,Teng Cuifang¹,Pang Yingxing¹,Wei Tongtong¹,Song Jinjing¹,Wang Hanlin³,Liao Xiaoli²,Li Yongqiang²,Yang Jie¹^ORCID

Affiliation:

1. Department of Pharmacology School of Pharmacy Guangxi Medical University Nanning Guangxi People’s Republic of China

2. Department of Chemotherapy Affiliated Cancer Hospital Guangxi Medical University Nanning Guangxi People’s Republic of China

3. Department of Internal Medicine First Affiliated Hospital Guangxi Medical University Nanning Guangxi People’s Republic of China

Funder

Natural Science Foundation of Guangxi Province

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.720

Reference60 articles.

1. Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels;Wang Q;Oncol Lett,2018

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer

4. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

5. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31

2. Upregulated lncRNA PRNT promotes progression and oxaliplatin resistance of colorectal cancer cells by regulating HIPK2 transcription;World Journal of Gastrointestinal Oncology;2024-04-15

3. Unveiling the connection: Long-chain non-coding RNAs and critical signaling pathways in breast cancer;Pathology - Research and Practice;2023-09

4. MiR-138-5p improves the chemosensitivity of MDA-MB-231 breast cancer cell line to paclitaxel;Molecular Biology Reports;2023-08-24

5. LncRNA UCA1 could regulate the progression of neuropathic pain by regulating miR-135a-5p;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2023-07